Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
Global X Telemedicine & Digital Health ETF
ETF
EDOC
Payout Change
Suspended
Price as of:
$8.76
-0.05
-0.57%
primary theme
Health Care Sector Equity
EDOC (ETF)
Global X Telemedicine & Digital Health ETF
Payout Change
Suspended
Price as of:
$8.76
-0.05
-0.57%
primary theme
Health Care Sector Equity
EDOC (ETF)
Global X Telemedicine & Digital Health ETF
Payout Change
Suspended
Price as of:
$8.76
-0.05
-0.57%
primary theme
Health Care Sector Equity
Name
As of 04/24/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-13.4%
1 yr return
-25.0%
3 Yr Avg Return
-24.1%
5 Yr Avg Return
N/A
Net Assets
$52.3 M
Holdings in Top 10
43.8%
52 WEEK LOW AND HIGH
$8.8
$8.09
$12.07
Expenses
OPERATING FEES
Expense Ratio 0.68%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 04/24/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
EDOC - Profile
Distributions
- YTD Total Return -13.4%
- 3 Yr Annualized Total Return -24.1%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -0.52%
- Dividend Yield 0.0%
- Dividend Distribution Frequency SemiAnnual
Fund Details
-
Legal NameGlobal X Telemedicine & Digital Health ETF
-
Fund Family NameGlobal X Funds
-
Inception DateJul 29, 2020
-
Shares Outstanding14319643
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerWayne Xie
Fund Description
The Fund invests at least 80% of its total assets, plus borrowings for investment purposes (if any), in the securities of the Solactive Telemedicine & Digital Health Index ("Underlying Index") and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the Underlying Index. The Fund's 80% investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Fund may lend securities representing up to one-third of the value of the Fund’s total assets (including the value of the collateral received).
The Underlying Index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of telemedicine and digital health, as well as applications thereof (collectively, "Telemedicine & Digital Health Companies"), as defined by Solactive AG, the provider of the Underlying Index (the "Index Provider"). In order to be eligible for inclusion in the Underlying Index, a company is considered by the Index Provider to be a Telemedicine & Digital Health Company if it derives at least 50% of its revenue, operating income, or assets from telemedicine and/or digital health. Telemedicine & Digital Health Companies include those involved in the following business activities: (i) telemedicine, (ii) healthcare analytics, (iii) connected healthcare devices, and/or (iv) administrative digitization.
In constructing the Underlying Index, the Index Provider first applies a proprietary natural language processing algorithm to the eligible universe, which seeks to identify and rank companies with direct exposure to the telemedicine and digital health industry based on filings, disclosures and other public information (e.g. regulatory filings, earnings transcripts, etc.). The
highest ranking companies identified by the natural language processing algorithm, as of the selection date, are further reviewed by the Index Provider to confirm they derive at least 50% of their revenues, operating income, or assets from the following business activities:
i.Telemedicine: Companies that connect physicians and patients digitally, facilitating a range of medical activities that include diagnosis, treatment, and medication management, as well as offering online pharmaceutical services, and/or providing internet healthcare platforms.
ii.Healthcare Analytics: Companies that collect, produce, utilize, and/or store data for healthcare related statistical and/or computational analyses, including artificial intelligence analyses and cloud-based analytics platforms.
iii.Connected Healthcare Devices: Companies that develop healthcare devices which automatically transmit data and results to patients and/or physicians to assist in real-time, dynamic patient treatment and preventative care.
iv.Administrative Digitization: Companies that enhance healthcare provider management processes including patient intake, staffing solutions, revenue/billing cycle management, digital healthcare security, as well as doctor/hospital search, booking and/or rating services for patient use.
The eligible universe of the Underlying Index includes exchange-listed companies that meet minimum market capitalization and liquidity criteria, as defined by the Index Provider. As of January 31, 2024, companies must have a minimum market capitalization of $200 million and a minimum average daily turnover for the last 6 months greater than or equal to $2 million in order to be eligible for inclusion in the Underlying Index. As of January 31, 2024, companies listed in the following countries were eligible for inclusion in the Underlying Index: Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, South Korea, Taiwan, the United Kingdom, and the United States.
The Underlying Index is weighted according to a modified capitalization weighting methodology and is reconstituted and re-weighted semi-annually. Modified capitalization weighting seeks to weight constituents primarily based on market capitalization, but subject to caps on the weights of the individual securities. Generally speaking, this approach will limit the amount of concentration in the largest market capitalization companies and increase company-level diversification. The Underlying Index may include large-, mid- or small-capitalization companies, and components primarily include healthcare companies. As of January 31, 2024, the Underlying Index had 38 constituents. The Fund's investment objective and Underlying Index may be changed without shareholder approval.
The Underlying Index is sponsored by the Index Provider, which is an organization that is independent of, and unaffiliated with, the Fund and Global X Management Company LLC, the investment adviser for the Fund ("Adviser"). The Index Provider determines the relative weightings of the securities in the Underlying Index and publishes information regarding the market value of the Underlying Index.
The Adviser uses a "passive" or indexing approach to try to achieve the Fund's investment objective. Unlike many investment companies, the Fund does not try to outperform the Underlying Index and does not seek temporary defensive positions when markets decline or appear overvalued.
The Fund generally will use a replication strategy. A replication strategy is an indexing strategy that involves investing in the securities of the Underlying Index in approximately the same proportions as in the Underlying Index. However, the Fund may utilize a representative sampling strategy with respect to the Underlying Index when a replication strategy might be detrimental or disadvantageous to shareholders, such as when there are practical difficulties or substantial costs involved in compiling a portfolio of equity securities to replicate the Underlying Index, in instances in which a security in the Underlying Index becomes temporarily illiquid, unavailable or less liquid, or as a result of legal restrictions or limitations (such as tax diversification requirements) that apply to the Fund but not the Underlying Index.
The Adviser expects that, over time, the correlation between the Fund's performance and that of the Underlying Index, before fees and expenses, will exceed 95%. A correlation percentage of 100% would indicate perfect correlation. If the Fund uses a replication strategy, it can be expected to have greater correlation to the Underlying Index than if it uses a representative sampling strategy.
The Fund concentrates its investments (i.e., holds 25% or more of its total assets) in a particular industry or group of industries to approximately the same extent that the Underlying Index is concentrated. As of January 31, 2024, the Underlying Index was concentrated in the health care equipment and supplies industry and had significant exposure to the health care sector.
EDOC - Performance
Return Ranking - Trailing
| Period | EDOC Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -13.4% | -29.9% | 12.8% | 98.16% |
| 1 Yr | -25.0% | -25.0% | 20.2% | 100.00% |
| 3 Yr | -24.1%* | -36.9% | 11.3% | 98.72% |
| 5 Yr | N/A* | -7.3% | 14.6% | 51.08% |
| 10 Yr | N/A* | 0.2% | 13.9% | 73.11% |
* Annualized
Return Ranking - Calendar
| Period | EDOC Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -12.6% | -12.6% | 19.0% | 99.39% |
| 2022 | -30.0% | -53.9% | 3.2% | 92.95% |
| 2021 | -14.2% | -39.6% | 24.2% | 75.64% |
| 2020 | N/A | -13.6% | 178.2% | N/A |
| 2019 | N/A | 3.8% | 63.8% | N/A |
Total Return Ranking - Trailing
| Period | EDOC Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -13.4% | -29.9% | 12.8% | 98.16% |
| 1 Yr | -25.0% | -25.0% | 20.2% | 100.00% |
| 3 Yr | -24.1%* | -36.9% | 11.3% | 98.72% |
| 5 Yr | N/A* | -7.3% | 14.6% | N/A |
| 10 Yr | N/A* | 0.2% | 13.9% | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | EDOC Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -12.6% | -12.6% | 19.0% | 100.00% |
| 2022 | -30.0% | -53.9% | 3.7% | 94.23% |
| 2021 | -14.2% | -33.9% | 26.0% | 90.38% |
| 2020 | N/A | -0.7% | 180.6% | N/A |
| 2019 | N/A | 4.6% | 63.8% | N/A |
EDOC - Holdings
Concentration Analysis
| EDOC | Category Low | Category High | EDOC % Rank | |
|---|---|---|---|---|
| Net Assets | 52.3 M | 7.41 M | 47.2 B | 80.98% |
| Number of Holdings | 38 | 23 | 413 | 88.96% |
| Net Assets in Top 10 | 28.4 M | 2.19 M | 20.5 B | 79.14% |
| Weighting of Top 10 | 43.76% | 18.1% | 77.0% | 61.35% |
Top 10 Holdings
- DEXCOM INC COMMON STOCK 5.18%
- AGILENT TECHNOLOGIES INC COMMON STOCK 4.67%
- PACIFIC BIOSCIENCES OF CALIF COMMON STOCK 4.56%
- RESMED INC-CDI DEPOSITARY RECEIPT 4.32%
- MASIMO CORP COMMON STOCK 4.31%
- IRHYTHM TECHNOLOGIES INC COMMON STOCK 4.27%
- JD HEALTH INTERNATIONAL INC COMMON STOCK 4.18%
- LABORATORY CRP OF AMER HLDGS COMMON STOCK 4.15%
- VERACYTE INC COMMON STOCK 4.09%
- DOXIMITY INC-CLASS A COMMON STOCK 4.04%
Asset Allocation
| Weighting | Return Low | Return High | EDOC % Rank | |
|---|---|---|---|---|
| Stocks | 99.88% | 87.17% | 106.13% | 12.27% |
| Cash | 0.12% | 0.00% | 32.99% | 91.41% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 74.23% |
| Other | 0.00% | -22.99% | 17.73% | 74.85% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 63.29% |
| Bonds | 0.00% | 0.00% | 12.39% | 67.48% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | EDOC % Rank | |
|---|---|---|---|---|
| Healthcare | 98.63% | 59.26% | 100.00% | 85.44% |
| Consumer Defense | 0.85% | 0.00% | 25.73% | 1.90% |
| Financial Services | 0.51% | 0.00% | 1.60% | 6.33% |
| Utilities | 0.00% | 0.00% | 0.00% | 60.13% |
| Technology | 0.00% | 0.00% | 22.69% | 63.92% |
| Real Estate | 0.00% | 0.00% | 5.89% | 62.66% |
| Industrials | 0.00% | 0.00% | 7.02% | 63.92% |
| Energy | 0.00% | 0.00% | 0.00% | 60.13% |
| Communication Services | 0.00% | 0.00% | 9.11% | 60.76% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 62.66% |
| Basic Materials | 0.00% | 0.00% | 7.16% | 68.99% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | EDOC % Rank | |
|---|---|---|---|---|
| US | 78.84% | 66.21% | 104.41% | 85.28% |
| Non US | 21.04% | 0.00% | 28.58% | 7.98% |
EDOC - Expenses
Operational Fees
| EDOC Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.68% | 0.08% | 4.28% | 77.30% |
| Management Fee | 0.68% | 0.03% | 1.25% | 49.69% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| EDOC Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| EDOC Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| EDOC Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 0.00% | 238.00% | N/A |
EDOC - Distributions
Dividend Yield Analysis
| EDOC | Category Low | Category High | EDOC % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 6.25% | 74.23% |
Dividend Distribution Analysis
| EDOC | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | SemiAnnual | Annual | Annual | Annual |
Net Income Ratio Analysis
| EDOC | Category Low | Category High | EDOC % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.52% | -2.54% | 1.85% | 70.51% |
Capital Gain Distribution Analysis
| EDOC | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually |
EDOC - Fund Manager Analysis
Managers
Wayne Xie
Start Date
Tenure
Tenure Rank
Jul 29, 2020
1.84
1.8%
Wayne Xie joined the Global X Management Company LLC in July 2018 as a Portfolio Management Associate. Previously, Mr. Xie was an Analyst at VanEck Associates on the Equity ETF Investment Management team from 2010 to 2018 and a Portfolio Administrator at VanEck Associates from 2007 to 2010. Mr. Xie received his BS in Business Administration from State University of New York at Buffalo.
Nam To
Start Date
Tenure
Tenure Rank
Jul 29, 2020
1.84
1.8%
Nam To, CFA, joined Global X Management Company LLC in July 2017 as a Portfolio Management Analyst. Mr. To has been a Portfolio Manager of the Fund since March 1, 2018. Previously, Mr. To was a Global Economics Research Analyst at Bunge Limited from 2014 through 2017 and an Advisory and Investment Analyst at Horizon Capital Group from June 2013 through August 2013. Mr. To received his Bachelor of Arts in Philosophy and Economics from Cornell University in 2014.
Kimberly Chan
Start Date
Tenure
Tenure Rank
Jul 29, 2020
1.84
1.8%
Kimberly Chan is a Portfolio Management Associate. Previously, Ms. Chan was a US Associate Trader at Credit Agricole from 2016 to 2018, and an Investment Analyst at MetLife Investments from 2015 to 2016. Ms. Chan received her Bachelor of Science from New York University in 2015.
Vanessa Yang
Start Date
Tenure
Tenure Rank
Dec 31, 2020
1.41
1.4%
Vanessa Yang, Portfolio Management Associate, joined Global X Management Company LLC in 2016 as a Portfolio Administrator. She was appointed to the portfolio management team in June 2019. Previously, Ms. Yang was a Portfolio Administrator at VanEck Associates from 2011 to 2014. Ms. Yang received her MS in Financial Engineering from Drucker School of Management in 2010 and her BS in Economics from Guangdong University of Foreign Studies in 2008.
Sandy Lu
Start Date
Tenure
Tenure Rank
Apr 01, 2022
0.16
0.2%
Sandy Lu, CFA, Portfolio Manager, joined the Adviser in September 2021. Previously, Mr. Lu worked at PGIM Fixed Income from 2014 to 2021, where he led the portfolio analyst team covering Emerging Markets Debt. He began his career in 2010 as an Investment Analyst at Lincoln Financial Group. Mr. Lu graduated with a B.S. in Economics from the Wharton School of the University of Pennsylvania. He earned his CFA designation in September 2015, and holds the Series 3 license.
William Helm
Start Date
Tenure
Tenure Rank
Apr 01, 2022
0.16
0.2%
William Helm, CFA, Portfolio Manager, joined the Adviser in September 2021. Previously, Mr. Helm spent 14 years at Vanguard where he most recently served as an Equity Portfolio Manager and Trader. Previously, he held roles in Portfolio Review, Corporate Strategy and Corporate Finance. Mr. Helm received his BBA in Economics from Belmont University in 2007 and his MBA from Columbia Business School in 2020.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.84 | 0.25 |
